These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3295650)

  • 1. Serum antimuscarinic activity after a single dose of oral scopolamine hydrobromide solution measured by radioreceptor assay.
    Markkanen YJ; Laurén L; Peltomäki T
    Oral Surg Oral Med Oral Pathol; 1987 May; 63(5):534-8. PubMed ID: 3295650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral scopolamine hydrobromide solution as an antisialagogic agent in dentistry.
    Markkanen YJ; Pihlajamäki K
    Oral Surg Oral Med Oral Pathol; 1987 Apr; 63(4):417-20. PubMed ID: 3472139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of scopolamine during caesarean section: relationship between serum concentration and effect.
    Kanto J; Kentala E; Kaila T; Pihlajamäki K
    Acta Anaesthesiol Scand; 1989 Aug; 33(6):482-6. PubMed ID: 2800990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of the effects of oral and i.m. atropine and hyoscine in volunteers.
    Mirakhur RK
    Br J Anaesth; 1978 Jun; 50(6):591-8. PubMed ID: 666935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioreceptor assay for determination of the antimuscarinic drug ipratropium bromide in man.
    Ensinger HA; Wahl D; Brantl V
    Eur J Clin Pharmacol; 1987; 33(5):459-62. PubMed ID: 2962877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volume and pH of gastric contents following anticholinergic premedication.
    Mirakhur RK; Reid J; Elliott J
    Anaesthesia; 1979 May; 34(5):453-7. PubMed ID: 38680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intramuscular atropine in elderly people: pharmacokinetic studies using the radioreceptor assay and some pharmacodynamic responses.
    Kentala E; Kaila T; Kanto J
    Pharmacol Toxicol; 1989 Aug; 65(2):110-3. PubMed ID: 2813282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimuscarinic activity of oxybutynin in the human plasma quantitated by a radioreceptor assay.
    Aaltonen L; Allonen H; Iisalo E; Juhakoski A; Kleimola T; Sellman R
    Acta Pharmacol Toxicol (Copenh); 1984 Aug; 55(2):100-3. PubMed ID: 6496110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of drugs given before anaesthesia. XVII: anticholinergic premedicants.
    Mirakhur RK; Dundee JW; Connolly JD
    Br J Anaesth; 1979 Apr; 51(4):339-45. PubMed ID: 380608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic receptor binding, plasma concentration and inhibition of salivation after oral administration of a novel antimuscarinic agent, solifenacin succinate in mice.
    Oki T; Sato S; Miyata K; Yamada S
    Br J Pharmacol; 2005 May; 145(2):219-27. PubMed ID: 15753946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic exercise produces tolerance to muscarinic antagonists in rats.
    McMaster SB; Carney JM
    Pharmacol Biochem Behav; 1986 Apr; 24(4):865-8. PubMed ID: 3714778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparisons of the cardiovascular and antisialogogue effects among glycopyrrolate, scopolamine and atropine in man.
    Hsu JC; Wong CS; Chen TS; Chang CL
    Ma Zui Xue Za Zhi; 1986 Mar; 24(1):39-44. PubMed ID: 3784806
    [No Abstract]   [Full Text] [Related]  

  • 13. AF-DX 116, a cardioselective muscarinic antagonist in humans: pharmacodynamic and pharmacokinetic properties.
    Schulte B; Volz-Zang C; Mutschler E; Horne C; Palm D; Wellstein A; Pitschner HF
    Clin Pharmacol Ther; 1991 Oct; 50(4):372-8. PubMed ID: 1914372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and clinical response of hyoscine plus morphine premedication in connection with cardiopulmonary bypass surgery.
    Kentala E; Kaila T; Arola M; Mattila M; Kanto J
    Eur J Anaesthesiol; 1991 Mar; 8(2):135-40. PubMed ID: 1874209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal scopolamine in drooling.
    Brodtkorb E; Wyzocka-Bakowska MM; Lillevold PE; Sandvik L; Saunte C; Hestnes A
    J Ment Defic Res; 1988 Jun; 32 ( Pt 3)():233-7. PubMed ID: 3047394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of radioreceptor assay and radioimmunoassay for atropine: pharmacokinetic application.
    Aaltonen L; Kanto J; Iisalo E; Pihlajamäki K
    Eur J Clin Pharmacol; 1984; 26(5):613-7. PubMed ID: 6468478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scopolamine blood levels following buccal versus ingested tablets.
    Golding JF; Gosden E; Gerrell J
    Aviat Space Environ Med; 1991 Jun; 62(6):521-6. PubMed ID: 1859338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic absorption of ocular scopolamine in patients.
    Lahdes K; Huupponen R; Kaila T; Salminen L; Iisalo E
    J Ocul Pharmacol; 1990; 6(1):61-6. PubMed ID: 2193993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Centrally active antimuscarinic analogs of oxotremorine selectively block physostigmine-induced hypertension, but not peripheral muscarinic vasodepression.
    Vargas HM; Ringdahl B
    J Pharmacol Exp Ther; 1990 Apr; 253(1):165-70. PubMed ID: 2329503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of atropine in connection with oral midazolam premedication.
    Sjövall S; Kanto J; Iisalo E; Kangas L; Mansikka M; Pihlajamäki K
    Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):184-8. PubMed ID: 6715087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.